Biotheus

Developer of antibody-based therapeutics for cancer treatment

placeZhuhai, Guangdong Province, China calendar_todayFounded 2018 language biotheus.com

Innovation

40 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 1,168 times.

YearFilings
20201
20216
20229
202322
202420
202526
20268

Investor mix

10 investors on record; lead investors include Highlight Capital, Shiyu, General Atlantic, IDG Capital; 3 have since exited.

Investor typeCountShare
Venture capital330%
Private equity770%
Coming soon